NASDAQ · Biotechnology
iBio, Inc. Common Stock (IBIO)
$0.80
-0.11%
52
In band
Moving averages
SMA 200$1.64-51.21%
Company profile
iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. The company is headquartered in New York, New York.
SectorHealthcare
IndustryBiotechnology
Market cap$53.00M
P/E ratioNone
EPS$-0.27
Beta1.474
Dividend yield0.00%
52-week high$3.82
52-week low$0.69
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
CGTX
Cognition Therapeutics Inc
RSI 29
CRBU
Caribou Biosciences Inc
RSI 22
HRTX
Heron Therapeutics Inc
RSI 39
BCTX
BriaCell Therapeutics Corp - New
RSI 44
CHRS
Coherus Biosciences Inc
RSI 24
BYSI
BeyondSpring Inc
RSI 37
RSI alerts for IBIO
An email when IBIO closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 4:08 AM EST